Patient info Open main menu

Topamax® 25 mg film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) ▼ Additional monitoring Details

Medicine strength:
25 mg
Contains active substance:
ATC code:

Patient leaflet - Topamax 25 mg film-coated tablets

1. What Topamax is and what it is used for

Topamax belongs to a group of medicines called “anti-epileptic medicines”. It is used:

  • alone to treat seizures in adults and children over age 6 ● with other medicines to treat seizures in adults and children aged

    2 years and above

  • to prevent migraine headaches in adults

2. What you need to know before you take Topamax

Do not take Topamax

  • if you are allergic to topiramate or any of the other ingredients

    of this medicine (listed in section 6).

Migraine prevention

  • You must not use Topamax if you are pregnant.
  • If you are a woman who is able to become pregnant, you must not

    take Topamax, unless you use highly effective contraception (birth control) during your treatment. See below under “Pregnancy, breast-feeding and fertility – Important advice for women”.

Treatment of epilepsy

  • You must not use Topamax if you are pregnant, unless no other

    treatment gives sufficient seizure control for you.

  • If you are a woman who is able to become pregnant, you must not

    take Topamax unless you use highly effective contraception (birth control) during your treatment. Do not stop taking Topamax or your contraception until you have discussed this with your doctor. Your doctor will advise you further and make sure you are aware of and understand all of the risks of taking Topamax during pregnancy and the risks of seizures during pregnancy. See below under “Pregnancy breast-feeding and fertility – Important advice for women”.

Make sure you read the patient guide that you will receive from your doctor.

A patient card is provided with the Topamax package to remind you of the risks in pregnancy.

If you are not sure if the above applies to you, talk to your doctor or pharmacist before using Topamax.

Warnings and precautions

Talk to your doctor before taking Topamax if you:

  • have kidney problems, especially kidney stones, or are getting

    kidney dialysis

  • have a history of blood and body fluid abnormality (metabolic acidosis) ● have liver problems
  • have eye problems, especially glaucoma
  • have a growth problem
  • are on a high fat diet (ketogenic diet)
  • are a woman who is able to become pregnant. Topamax can harm

    an unborn child when taken during pregnancy. Highly effective contraception (birth control) must be used during your treatment and for at least 4 weeks after the last Topamax dose. See section ‘pregnancy and breast-feeding’ for further information. ● are pregnant. Topamax can harm an unborn child when taken

    during pregnancy.

If you are not sure if any of the above apply to you, talk to your doctor before using Topamax.

If you have epilepsy, it is important that you do not stop taking your medicine without first consulting your doctor.

You should also talk to your doctor before taking any medicine containing topiramate that is given to you as an alternative to Topamax.

You may lose weight if you use Topamax so your weight should be checked regularly when using this medicine. If you are losing too much weight or a child using this medicine is not gaining enough weight, you should consult your doctor.

A small number of people being treated with anti-epileptic medicines such as Topamax have had thoughts of harming or killing themselves. If at any time you have these thoughts, immediately contact your doctor.

Topamax can cause serious skin reactions, tell your doctor immediately if you develop a skin rash and/or blisters (see also section 4 ‘Possible side effects’).

Topamax may in rare cases cause high levels of ammonia in the blood (seen in blood tests) which can lead to a change in brain function, especially if you are also taking a medicine called valproic acid or sodium valproate. Since this may be a severe condition, tell your doctor immediately if the following symptoms occur (see also section 4 ‘Possible side effects’):

  • difficulty thinking, remembering information, or solving problems ● being less alert or aware
  • feeling very sleepy with low energy

At higher doses of Topamax, the risk of developing these symptoms may increase.

Other medicines you should discuss with your doctor or pharmacist include other anti-epileptic medicines, digoxin, risperidone, lithium, hydrochlorothiazide, metformin, pioglitazone, glibenclamide, amitriptyline, haloperidol, propranolol, diltiazem, venlafaxine, flunarazine, St. John’s wort (Hypericum perforatum) (a herbal preparation used to treat depression), warfarin used to thin the blood.

If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before using Topamax.

Topamax with food and drink

You can take Topamax with or without food. Drink plenty of fluids during the day to prevent kidney stones while taking Topamax. You should avoid drinking alcohol when taking Topamax.

Pregnancy, breast-feeding and fertility

Important advice for women who are able to become pregnant Topamax can harm an unborn child. If you are a woman who is able to become pregnant, talk to your doctor about other possible treatments. Visit your doctor to review your treatment and discuss the risks at least once a year.

Migraine prevention:

  • For migraine, you must not use Topamax if you are pregnant. ● For migraine, you must not use Topamax if you are a woman who

    is able to become pregnant unless you are using highly effective contraception (birth control).

  • Before the start of treatment with Topamax a pregnancy test should

    be performed in a woman who is able to become pregnant.

Treatment of epilepsy:

  • For epilepsy, you must not use Topamax if you are pregnant, unless

    you and your doctor have agreed that no other treatment gives sufficient seizure control for you.

  • For epilepsy, you must not use Topamax if you are a woman who

    is able to become pregnant unless you are using highly effective contraception. Do not stop taking Topamax or your contraception (birth control) until you have discussed this with your doctor. Your doctor will make sure you have received information about the risks of taking Topamax during pregnancy and about the risks of seizures during pregnancy, which may put you or your unborn child at risk. ● Before the start of treatment with Topamax a pregnancy test should

    be performed in a woman who is able to become pregnant.

The risks of topiramate when taken during pregnancy. The risks apply whether topiramate is taken for migraine prevention or treatment of epilepsy.

There is a risk of harm to the unborn child if Topamax is used during pregnancy.

  • If you take Topamax during pregnancy, your child has a higher

    risk for birth defects. In women who take topiramate, around 4 - 9 children in every 100 will have birth defects. This compares to 1-3 children in every 100 born to women who do not have epilepsy and do not take an antiepileptic treatment. Particularly, cleft lip (split in the top lip) and cleft palate (split in the roof of the mouth) have been observed. Newborn boys may also have a malformation of the penis (hypospadia). These defects can develop early in pregnancy, even before you know you are pregnant. ● If you take Topamax during pregnancy, your child may have

    a 2- to 3-fold higher risk for autism spectrum disorders, intellectual disabilities, or attention deficit hyperactivity disorder (ADHD) compared with children born to women with epilepsy not taking antiepileptic medication.

  • If you take Topamax during pregnancy, your child may be smaller

    and weigh less than expected at birth. In one study, around 18 in every 100 children of mothers taking topiramate during pregnancy were smaller and weighed less than expected at birth, while around 5 in every 100 children born to women without epilepsy and not taking antiepileptic medication were smaller and weighed less than expected at birth.

  • Talk to your doctor if you have questions about this risk

    during pregnancy.

  • There may be other medicines to treat your condition that have

    a lower risk of birth defects.

Need for contraception (birth control) in women who are able to become pregnant:

  • If you are a woman who is able to become pregnant, talk to your

    doctor about other possible treatments instead of Topamax. If the decision is made to use Topamax, you must use highly effective contraception during your treatment and for at least 4 weeks after the last Topamax dose.

  • One highly effective contraception (such as an intrauterine device)

    or two complementary contraceptives such as birth control pill together with a barrier method of birth control (such as a condom or pessary/diaphragm) must be used. Talk to your doctor about what contraception is most appropriate for you.

  • Topamax can affect how well some hormonal contraceptive

    (birth control) methods work. If you are taking hormonal contraceptives, an additional barrier contraceptive method (such as a condom or pessary/diaphragm) should be used. ● Tell your doctor if you experience irregular menstrual bleeding.

Use of Topamax in girls:

If you are a parent or a caregiver of a girl treated with Topamax, you must contact her doctor immediately once your child experiences her first period (menarche). The doctor will inform you about the risks to an unborn child due to topiramate exposure during pregnancy, and the need for using highly effective contraception.

If you wish to become pregnant while taking Topamax: ● Schedule an appointment with your doctor.

  • Do not stop using your contraception until you have discussed this

    with your doctor.

  • If you take Topamax for epilepsy, do not stop taking it until you have

    discussed this with your doctor. Suddenly stopping Topamax can cause seizures to start again or happen more often or last longer than before. This may put you or your unborn child at risk. ● Your doctor will reassess your treatment as they may need to change

    or stop your medicine. The doctor will counsel you about the risks of Topamax during pregnancy. He/she may also refer you to another specialist.

    Breast-feeding

    The active substance in Topamax (topiramate)

    passes into human milk. Effects have been seen in breastfed babies of treated mothers, including diarrhea, feeling sleepy, feeling irritable, and poor weight gain. Therefore, your doctor will discuss with you whether you abstain from breast-feeding or whether to abstain from treatment with Topamax. Your doctor will take into account the importance of the medicine to the mother and the risk for the baby. Mothers who breast-feed while taking Topamax must tell the doctor as soon as possible if the baby experiences anything unusual.

    Driving and using machines

    Dizziness, tiredness, and vision problems may occur during treatment with Topamax. Do not drive or use any tools or machines without talking to your doctor first.

    Topamax contains lactose

    If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

    Other ingredients

    This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Topamax

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. ● Your doctor will usually start you on a low dose of Topamax and slowly increase your dose until the best dose is found for you. ● Topamax tablets are to be swallowed whole. Avoid chewing the tablets as they may leave a bitter taste.

  • Topamax can be taken before, during, or after a meal.

    Drink plenty of fluids during the day to prevent kidney stones while taking Topamax.

If you take more Topamax than you should

  • See a doctor right away. Take the medicine pack with you. ● You may feel sleepy, tired, or less alert; lack coordination; have difficulty speaking or concentrating; have double or blurred vision; feel dizzy due to low blood pressure; feel depressed or agitated; or have abdominal pain, or seizures (fits).

Overdose can happen if you are taking other medicines together with Topamax.

If you forget to take Topamax

  • If you forget to take a dose, take it as soon as you remember it.

    However, if it is almost time for your next dose, skip the missed dose and continue as usual. If you miss two or more doses, contact your doctor.

  • Do not take a double dose (two doses at the same time) to make up for a forgotten dose.

If you stop taking Topamax

Do not stop taking this medicine unless told to do so by your doctor. Your symptoms may return. If your doctor decides to stop this medication, your dose may be decreased gradually over a few days.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor, or seek medical attention immediately if you have the following side effects:

Very common (may affect more than 1 in 10 people)

  • Depression (new or worse)

Common (may affect up to 1 in 10 people)

  • Seizures (fits)
  • Anxiety, irritability, changes in mood, confusion, disorientation ● Problems with concentration, slowness of thinking, loss of memory, problems with memory (new onset, sudden change or increased severity)
  • Kidney stone, frequent or painful urination

Uncommon (may affect up to 1 in 100 people)

  • Increased acid level in the blood (may cause troubled breathing including shortness of breath, loss of appetite, nausea, vomiting, excessive tiredness, and fast or uneven heart beats) ● Decreased or loss of sweating (particularly in young children who are exposed to high temperatures)
  • Having thoughts of serious self-harm, trying to cause serious self-harm ● Loss of part of the field of vision

Rare (may affect up to 1 in 1,000 people)

  • Glaucoma – blockage of fluid in eye causing increased pressure in the eye, pain, or decreased vision
  • Difficulty thinking, remembering information, or solving problems, being less alert or aware, feeling very sleepy with low energy

    • these symptoms may be a sign of a high level of ammonia in the blood (hyperammonemia), which can lead to a change in brain function (hyperammonemic encephalopathy).
  • Serious skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis - these may appear as rashes with or without blisters. Skin irritation, sores or swelling in the mouth, throat, nose, eyes and around the genitals. The skin rashes may develop into serious widespread skin damage (peeling of the epidermis and superficial mucous membranes) with life-threatening consequences. Not known (frequency cannot be estimated from the available data)
  • Inflammation of the eye (uveitis) with symptoms such as eye redness, pain, sensitivity to light, runny eyes, seeing small dots or getting blurred vision

Other side effects include the following, if they get serious, please tell your doctor or pharmacist:

Very common (may affect more than 1 in 10 people)

  • Stuffy, runny nose or sore throat
  • Tingling, pain and/or numbness of various body parts ● Sleepiness, tiredness
  • Dizziness
  • Nausea, diarrhoea
  • Weight loss

Common (may affect up to 1 in 10 people)

  • Anaemia (low blood count)
  • Allergic reaction (such as skin rash, redness, itching,

    facial swelling, hives)

  • Loss of appetite, decreased appetite
  • Aggression, agitation, anger, abnormal behaviour ● Difficulty falling or staying asleep
  • Problems with speech or speech disorder, slurred speech ● Clumsiness or lack of coordination, feeling of unsteadiness

    when walking

  • Decreased ability to complete routine tasks
  • Decreased, loss of, or no sense of taste
  • Involuntary trembling or shaking; rapid, uncontrollable movements

    of the eyes

  • Visual disturbance, such as double vision, blurred vision,

    decreased vision, difficulty focusing

  • Sensation of spinning (vertigo), ringing in the ears, ear pain ● Shortness of breath
  • Cough
  • Nose bleeds
  • Fever, not feeling well, weakness
  • Vomiting, constipation, abdominal pain or discomfort, indigestion,

    stomach or intestinal infection

  • Dry mouth
  • Hair loss
  • Itching
  • Joint pain or swelling, muscle spasms or twitching, muscle aches

    or weakness, chest pain

  • Weight gain

Uncommon (may affect up to 1 in 100 people)

  • Decrease in platelets (blood cells that help stop bleeding),

    decrease in white blood cells that help to protect you against infection, decrease in potassium level in the blood ● Increase in liver enzymes, increase in eosinophils

    (a type of white blood cell) in the blood

  • Swollen glands in the neck, armpit, or groin
  • Increased appetite
  • Elevated mood
  • Hearing, seeing, or feeling things that are not there, severe mental

    disorder (psychosis)

  • Showing and/or feeling no emotion, unusual suspiciousness,

    panic attack

  • Problems with reading, speech disorder, problems with handwriting ● Restlessness, hyperactivity
  • Slowed thinking, decreased wakefulness or alertness ● Reduced or slow body movements, involuntary abnormal

    or repetitive muscle movements

  • Fainting
  • Abnormal sense of touch; impaired sense of touch ● Impaired, distorted, or no sense of smell
  • Unusual feeling or sensation that may precede a migraine

    or a certain type of seizure

  • Dry eye, sensitivity of the eyes to light, eyelid twitching, watery eyes ● Decreased or loss of hearing, loss of hearing in one ear ● Slow or irregular heartbeat, feeling your heart beating in your chest ● Low blood pressure, low blood pressure upon standing

    (consequently, some people taking Topamax may feel faint, dizzy, or may pass out when they stand up or sit up suddenly) ● Flushing, feeling warm

  • Pancreatitis (inflammation of the pancreas)
  • Excessive passing of gas or wind, heartburn, abdominal fullness

    or bloating

  • Bleeding gums, increased saliva, drooling, breath odour ● Excessive intake of fluids, thirst
  • Skin discolouration
  • Muscle stiffness, pain in side
  • Blood in urine, incontinence (lack of control) of urine,

    urgent desire to urinate, flank or kidney pain

  • Difficulty getting or keeping an erection, sexual dysfunction ● Flu-like symptoms
  • Cold fingers and toes
  • Feeling drunk
  • Learning disability

Rare (may affect up to 1 in 1,000 people)

  • Abnormally elevated mood
  • Loss of consciousness
  • Blindness in one eye, temporary blindness, night blindness ● Lazy eye
  • Swelling in and around the eyes
  • Numbness, tingling and colour change (white, blue then red)

    in fingers and toes when exposed to the cold

  • Inflammation of the liver, liver failure
  • Abnormal skin odour
  • Discomfort in your arms or legs
  • Kidney disorder

Not known (frequency cannot be estimated from the available data)

  • Maculopathy is a disease of the macula, the small spot in the retina

    where vision is keenest. You should call your doctor if you notice a change or decrease in your vision. )

Children

The side effects in children are generally similar to those seen in adults, but the following side effects may be more common in children than adults:

  • Problems with concentration
  • Increased acid level in the blood
  • Having thoughts of serious self-harm
  • Tiredness
  • Decreased or increased appetite
  • Aggression, abnormal behaviour
  • Difficulty falling or staying asleep
  • Feeling of unsteadiness when walking
  • Not feeling well
  • Decrease in potassium level in the blood
  • Showing and/or feeling no emotion
  • Watery eyes
  • Slow or irregular heartbeat

Other side effects that may occur in children are:

Common (may affect up to 1 in 10 people)

  • Sensation of spinning (vertigo)
  • Vomiting
  • Fever

Uncommon (may affect up to 1 in 100 people)

  • Increase in eosinophils (a type of white blood cell) in the blood ● Hyperactivity
  • Feeling warm
  • Learning disability

Reporting of side effects

By reporting side effects, you can help provide more information on the safety of this medicine.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:

www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

5. How to store Topamax

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle and carton after EXP. The expiry date refers to the last day of that month.

Do not store above 25°C.

Store in the original package and keep the bottle tightly closed to protect the tablets from moisture.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Topamax contains

  • Each film-coated tablet contains 25mg of topiramate. ● Topamax also contains the following inactive ingredients:

    Core tablets:

    lactose monohydrate, pregelatinized starch, microcrystalline cellulose, sodium starch glycollate, magnesium stearate Film coating:

    carnauba wax and Opadry White

    The Opadry white contains:

    hypromellose, titanium dioxide (E171), macrogol and polysorbate 80.

What Topamax looks like and contents of the pack

Topamax Tablets are white round tablets marked TOP on one side and 25 on the other.

In each bottle, there is a desiccant canister which should not be swallowed.

Topamax Tablets are available in plastic bottles of 60 tablets.

Manufacturers

Janssen Pharmaceutica N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium

or

Janssen-Cilag S.p.A., 04100 Borgo S. Michele, Latina, Italy or

Lusomedicamenta – Sociedade Técnica, Farmacêutica S.A., Estrada Consiglieri Pedroso n° 69 B, Queluz de Baixo, 2730-055 Barcarena, Portugal

Procured from within the EU and repackaged for the PL Holder:

Abacus Medicine Ltd., Abbey House,

282 Farnborough Road, Farnborough,

GU14 7NA, United Kingdom

PL 45763/1779 POM

Topamax® is a registered trademark of Johnson & Johnson.

For any information about this medicine, please contact the local representative of the Product Licence Holder:

Abacus Medicine Ltd.

tel: +44(0)2036301244,

email: MedInfo@abacusmedicine.co.uk or drugsafetyuk@abacusmedicine.co.uk

This leaflet was last revised in 28.04.2026.

Blind or partially sighted? Is this leaflet hard to see or read? Call 02036301310 or write to info@abacusmedicine.com to obtain the leaflet in a format suitable for you.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 45763/1779

Last revision stated in the text: 28 April 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Topamax 25 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Topiramate
Strength 25 mg
Pharmaceutical form Oral tablet
White round tablets, 6 mm in diameter, “TOP” on one side, “25” on the other side.
How is it taken Oral
Pack sizes 60 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months
Storage Do not store above 25°C.
Blisters: Store in the original package to protect the tablets from moisture. Bottles: Store in the original package and keep the bottle tightly closed to protect the tablets from moisture.
Drug group (ATC) Antiepileptics, other antiepileptics
  1. N Nervous system drugs
    1. N03 Antiepileptics
      1. N03A Antiepileptics
        1. N03AX Other antiepileptics
          1. N03AX11 topiramate
Additional monitoring Yes ▼ – new safety information is collected quickly. Report any side effect to the Yellow Card scheme.
Marketing authorisation PL 00242/0301 (first authorised 18 July 1995), PLPI 45763/1779
Marketing authorisation holder Janssen-Cilag Limited
Codes GTIN 5012946026063 · BNF 04080100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.